Prevalence of Modifiable Risk Factors for de novo Malignancies After Living Donor Liver Transplantation
J Clin Exp Hepatol
.
2024 May-Jun;14(3):101362.
doi: 10.1016/j.jceh.2024.101362.
Epub 2024 Feb 17.
Authors
Narendra S Choudhary
1
,
Ajay Podisatti
1
,
Swapnil Dhampalwar
1
,
Kunwar A Singh
1
,
Neeraj Saraf
1
,
Arvinder S Soin
1
Affiliation
1
Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India.
PMID:
38495075
PMCID:
PMC10937305
(available on
2025-05-01
)
DOI:
10.1016/j.jceh.2024.101362
No abstract available